Conclusions
Key EGM selection reduced the EGM burden by 55%, with no delay-to-diagnosis in 99% of patients who exhibited a true arrhythmia. Implementing these rules by enabling a feature on the manufacturer’s patient care network may accelerate clinical workflow without compromising diagnostic timelines, ultimately streamlining ICM patient management.